And so another day begins. Our immediate challenge is hustling the short people off to their respective schoolhouses. This calls for a cup or three of stimulation. Meanwhile, the usual meetings and deadlines loom, although we look forward to a gathering this evening of industry types. As we all prepare for what lies ahead, here are a few items to help you along. Have a good one...
German Court Rules Glaxo's Advair Patent Isn't Valid (Reuters)
Piramal Downplays Takeover Rumors (PharmaTimes)
Vanda Schizophrenia Drugs Gets Bad Review (TheStreet)
PhRMA Spent $7M Lobbying DC In 1st Quarter (Associated Press)
Roche Diagnostics Insists It's Growing (Indianapolis Star)